Investing Profile

Andrew Sinclair

InvestorVC
Partner, Portfolio Manager at Abingworth
Photo of Andrew Sinclair, Partner at Abingworth

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Abingworth Partner
$15.0M - $30.0M
$22.5M
4
$465M
CompanyStageDateRound SizeTotal Raised
R1 Therapeutics
Series AMar 2026$78M
$78M
Co-investors: Chong Xu (F-Prime Capital Partners), Ben Auspitz (Forge Life Science Partners)
Ascend Gene & Cell Therapies
Series AMar 2023$66M
$66M
Co-investors: Bali Muralidhar (Abingworth)
Entact Bio
Series ADec 2022$81M
$81M
Co-investors: Richard Gaster (venBio)
Soleno Therapeutics
Post Ipo EquityDec 2018$17M
$17M
Partner, Portfolio Manager Abingworth2008 - Present